DiscGenics is a privately held, clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine.
DiscGenics is harnessing the restorative potential of cells native to the intervertebral disc to develop what we hope will be a profound therapeutic option for millions of patients suffering from the debilitating effects of back pain.
DiscGenics’ first product candidate, IDCT, is a homologous, allogeneic, injectable cell therapy for the treatment of patients with mild to moderate degenerative disc disease.
Company Details
- Employees
- 37
- Founded
- -
- Address
- 5940 W Harold Gatty Dr, Salt Lake City,utah 84116,united States
- Phone
- 801-410-0703
- in****@****ics.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- discgenics.com
- HQ
- Salt Lake City, Utah
Discgenics Questions
Discgenics's helpline number is 801-410-0703
Discgenics's website is discgenics.com
Discgenics's LinkedIn profile is https://www.linkedin.com/company/discgenics
Discgenics has
37 employees.
View email and phone details for 37
employees at Discgenics.
Discgenics's industry is
Biotechnology Research
Discgenics's top competitors are
Nelson Labs,
Indapta Therapeutics,
Halia Therapeutics, Inc.,
Renew Biotechnologies,
Sintx Technologies,
Regeltec, Inc,
Altitude Lab,
Tr1x,
Nusano,
Mesoblast Limited.
Discgenics's support email address is info@discgenics.com
Discgenics's categories are Biotechnology Research
Discgenics's founding year is 2007
